Dendritic cells loaded with pancreatic cancer stem cells (CSCs) lysates induce antitumor immune killing effect in vitro

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Yin, Tao ^a   Shi, Pengfei ^a   Gou, Shanmiao ^a   Shen, Qiang ^b   Wang, Chunyou ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD86 ANTIGEN; GAMMA INTERFERON; HLA ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2; LACTATE DEHYDROGENASE; CELL EXTRACT;

ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CANCER STEM CELL; CELL KILLING; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; PANCREAS CANCER; PHENOTYPE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TUMOR IMMUNITY; UPREGULATION; CELL CULTURE; CHEMISTRY; DRUG EFFECTS; GENETICS; IMMUNOLOGY; LYMPHOCYTE; METABOLISM; PANCREAS TUMOR; TUMOR CELL LINE;

ANTIGENS, CD86; CELL EXTRACTS; CELL LINE, TUMOR; CELLS, CULTURED; DENDRITIC CELLS; HLA ANTIGENS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; NEOPLASTIC STEM CELLS; PANCREATIC NEOPLASMS;

EID: 84942379334     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114581     Document Type: Article

References (21)

1. Li D, Xie K, Wolff R, Abbruzzese JL (2004) Pancreatic cancer. Lancet 363(9414): 1049-57.
2. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, et al. (2007) Identification of pancreatic CSCs. Cancer Res 67(3): 1030-7.
3. Li X, Lewis MT, Huang J, Gutierrez C, Osborne CK, et al. (2008) Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 100(9): 672-9.
4. Mimeault M, Hauke R, Mehta PP, Batra SK (2007) Recent advances in cancer stem/progenitor cell research: Therapeutic implications for overcoming resistance to the most aggressive cancers. J Cell Mol Med 11(5): 981-1011.
5. Xu Q, Liu G, Yuan X, Xu M, Wang H, et al. (2009) Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens. Stem Cells 27(8): 1734-40.
6. Spisek R, Kukreja A, Chen LC, Matthews P, Mazumder A, et al. (2007) Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy. J Exp Med 204(4): 831-40.
7. Brown CE, Starr R, Martinez C, Aguilar B, D'Apuzzo M, et al. (2009) Recognition and killing of brain tumor stem-like initiating cells by CD8+ cytolytic T cells. Cancer Res 69(23): 8886-93.
8. Hayashi T, Tanaka H, Tanaka J, Wang R, Averbook BJ, et al. (2002) Immunogenicity and therapeutic efficacy of dendritic-tumor hybrid cells generated by electrofusion. Clin Immunol 104(1): 14-20.
9. Gou S, Liu T, Wang C, Yin T, Li K, et al. (2007) Establishment of clonal colony-forming assay for propagation of pancreatic cancer cells with stem cell properties. Pancreas 34(4): 429-35.
10. Yin T, Wei H, Gou S, Shi P, Yang Z, et al. (2011) Cancer stem-like cells enriched in panc-1 spheres possess increased migration ability and resistance to gemcitabine. Int J Mol Sci 12(3): 1595-604.
11. Simeone DM (2008) Pancreatic CSCs: implications for the treatment of pancreatic cancer. Clin Cancer Res 14(18): 5646-8.
12. Wu A, Wiesner S, Xiao J, Ericson K, Chen W, et al. (2007) Expression of MHC I and NK ligands on human CD133+ glioma cells: possible targets of immunotherapy. J Neurooncol 83(2): 121-31.
13. Wei J, Barr J, Kong LY, Wang Y, Wu A, et al. (2010) Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway. Mol Cancer Ther 9(1): 67-78.
14. Schatton T, Schü tte U, Frank NY, Zhan Q, Hoerning A, et al. (2010) Modulation of T-cell activation by malignant melanoma initiating cells. Cancer Res 70(2): 697-708.
15. Wei J, Barr J, Kong LY, Wang Y, Wu A, et al. (2010) Glioma-associated cancer-initiating cells induce immunosuppression. Clin Cancer Res 16(2): 461-73.
16. Goldszmid RS, Idoyaga J, Bravo AI, Steinman R, Mordoh J, et al. (2003) Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma. J Immunol 171(11): 5940-7.
17. Vik-Mo EO, Nyakas M, Mikkelsen BV, Moe MC, Due-Tønnesen P, et al. (2013) Therapeutic vaccination against autologous CSCs with mRNA-transfected dendritic cells in patients with glioblastoma. Cancer Immunol Immunother 62(9): 1499-509.
18. Pellegatta S, Poliani PL, Corno D, Menghi F, Ghielmetti F, et al. (2006) Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas. Cancer Res 66(21): 10247-52.
19. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, et al. (2007) Distinct populations of CSCs determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1(3): 313-23.
20. Lee HJ, You DD, Choi DW, Choi YS, Kim SJ, et al. (2011) Significance of CD133 as a CSC markers focusing on the tumorigenicity of pancreatic cancer cell lines. J Korean Surg Soc 81(4): 263-70.
21. Ma S1, Chan KW, Lee TK, Tang KH, Wo JY, et al. (2008) Aldehyde dehydrogenase discriminates the CD133 liver CSC populations. Mol Cancer Res 6(7): 1146-53.